OKYO Pharma Limited (OKYO)
NASDAQ: OKYO · Real-Time Price · USD
1.385
+0.005 (0.36%)
At close: Sep 25, 2026, 4:00 PM EDT
1.380
-0.005 (-0.36%)
After-hours: Sep 25, 2026, 7:30 PM EDT
OKYO Pharma Balance Sheet
Financials in millions USD. Fiscal year is April - March.
Millions USD. Fiscal year is Apr - Mar.
Assets
Fiscal Quarter | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 |
Cash & Equivalents | 14.59 | 14.59 | 4.22 | 4.22 | 1.56 | 1.56 | 0.99 | 0.99 | 0.83 | 0.83 |
Short-Term Investments | 6 | 6 | - | - | - | - | - | - | - | - |
Cash & Short-Term Investments | 20.59 | 20.59 | 4.22 | 4.22 | 1.56 | 1.56 | 0.99 | 0.99 | 0.83 | 0.83 |
Cash Growth (YoY) | 1219.38% | 1219.38% | 327.51% | 327.51% | 88.78% | 88.78% | - | -75.60% | - | - |
Other Receivables | 0.17 | 0.17 | 0.02 | 0.02 | 1.89 | 1.89 | 1.52 | 1.52 | 0.58 | 0.58 |
Receivables | 0.17 | 0.17 | 0.02 | 0.02 | 1.89 | 1.89 | 1.52 | 1.52 | 0.58 | 0.58 |
Prepaid Expenses | 0.21 | 0.21 | 0.39 | 0.39 | 0.23 | 0.23 | 0.32 | 0.32 | 0.13 | 0.13 |
Other Current Assets | - | - | 0 | 0 | - | - | 0 | 0 | - | - |
Total Current Assets | 20.97 | 20.97 | 4.64 | 4.64 | 3.68 | 3.68 | 2.83 | 2.83 | 1.54 | 1.54 |
Property, Plant & Equipment | 0.01 | 0.01 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Assets | 20.98 | 20.98 | 4.64 | 4.64 | 3.68 | 3.68 | 2.83 | 2.83 | 1.54 | 1.54 |
Liabilities
Fiscal Quarter | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 |
Accounts Payable | 7.14 | 7.14 | 7.64 | 7.64 | 7.9 | 7.9 | 9.61 | 9.61 | 6.13 | 6.13 |
Accrued Expenses | 1.5 | 1.5 | - | - | 0.38 | 0.38 | - | - | 1.19 | 1.19 |
Short-Term Debt | - | - | 0.19 | 0.19 | - | - | 0 | 0 | - | - |
Other Current Liabilities | 0 | 0 | 0.23 | 0.23 | 0.95 | 0.95 | 0.45 | 0.45 | 0.1 | 0.1 |
Total Current Liabilities | 8.64 | 8.64 | 8.06 | 8.06 | 9.23 | 9.23 | 10.05 | 10.05 | 7.42 | 7.42 |
Total Liabilities | 8.64 | 8.64 | 8.06 | 8.06 | 9.23 | 9.23 | 10.05 | 10.05 | 7.42 | 7.42 |
Shareholders' Equity
Fiscal Quarter | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 |
Additional Paid-In Capital | 173.56 | 173.56 | 151.23 | 151.23 | 146.72 | 146.72 | 144.05 | 144.05 | 143.11 | 143.11 |
Retained Earnings | -151.97 | -151.97 | -145.61 | -145.61 | -143.02 | -143.02 | -145.2 | -145.2 | -142.52 | -142.52 |
Comprehensive Income & Other | -9.25 | -9.25 | -9.03 | -9.03 | -9.24 | -9.24 | -6.07 | -6.07 | -6.47 | -6.47 |
Shareholders' Equity | 12.34 | 12.34 | -3.42 | -3.42 | -5.55 | -5.55 | -7.23 | -7.23 | -5.88 | -5.88 |
Total Liabilities & Equity | 20.98 | 20.98 | 4.64 | 4.64 | 3.68 | 3.68 | 2.83 | 2.83 | 1.54 | 1.54 |
Additional Metrics
Fiscal Quarter | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 |
Total Debt | - | - | 0.19 | 0.19 | - | - | 0 | 0 | - | - |
Net Cash (Debt) | 20.59 | 20.59 | 4.03 | 4.03 | 1.56 | 1.56 | 0.99 | 0.99 | 0.83 | 0.83 |
Net Cash Growth (YoY) | 1219.38% | 1219.38% | 309.44% | 309.44% | 88.78% | 88.78% | - | -46.16% | - | - |
Net Cash Per Share | 0.55 | 0.52 | 0.10 | 0.10 | 0.04 | 0.04 | 0.03 | 0.03 | 0.03 | 0.03 |
Filing Date Shares Outstanding | 52.48 | 52.48 | 38.45 | 38.45 | 37.61 | 37.61 | 33.94 | 33.94 | 33.84 | 32.97 |
Total Common Shares Outstanding | 52.48 | 52.48 | 38.45 | 38.45 | 36.02 | 36.02 | 33.94 | 33.94 | 33.34 | 32.97 |
Working Capital | 12.33 | 12.33 | -3.42 | -3.42 | -5.55 | -5.55 | -7.23 | -7.23 | -5.88 | -5.88 |
Book Value Per Share | 0.24 | 0.24 | -0.09 | -0.09 | -0.15 | -0.15 | -0.21 | -0.21 | -0.18 | -0.18 |
Tangible Book Value | 12.34 | 12.34 | -3.42 | -3.42 | -5.55 | -5.55 | -7.23 | -7.23 | -5.88 | -5.88 |
Tangible Book Value Per Share | 0.24 | 0.24 | -0.09 | -0.09 | -0.15 | -0.15 | -0.21 | -0.21 | -0.18 | -0.18 |
Machinery | 0.02 | 0.02 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |